Form D · Biotechnology
RiverTown Therapeutics, Inc.
Dobbs Ferry, NY · CIK 0001672054
Offering snapshot reported Apr 13, 2016 · SEC filing
- Reported sold
- $133K Offering amount: $15M
- Investors reported
- 3 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Apr 8, 2016 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Apr 13, 2016 | Initial | $133,000 | No comparison | 3 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-261264
Source: Form D, filed Apr 13, 2016. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Michael Altman | Director, Executive |
| David Weinstein | Director, Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
39 Round Hill Road
Dobbs Ferry, NY, 10522
Dobbs Ferry, NY, 10522